Randomized clinical trial to compare efficacy and safety of repeated courses of rituximab to single-course rituximab followed by maintenance mycophenolate-mofetil in children with steroid dependent nephrotic syndrome

Approximately 30% of children with idiopathic nephrotic syndrome develop a complicated course with frequent relapses or steroid dependency. Rituximab, a B cell depleting monoclonal antibody, is a safe and effective alternative to steroids or other immunosuppressants for achieving and maintaining rem...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Basu, Biswanath (VerfasserIn) , Erdmann, Stella (VerfasserIn) , Sander, Anja (VerfasserIn) , Mahapatra, T. K. S. (VerfasserIn) , Schaefer, Franz (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 30 November 2020
In: BMC nephrology
Year: 2020, Jahrgang: 21, Pages: 1-11
ISSN:1471-2369
DOI:10.1186/s12882-020-02153-5
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12882-020-02153-5
Verlag, kostenfrei, Volltext: https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-020-02153-5
Volltext
Verfasserangaben:Biswanath Basu, Stella Preussler, Anja Sander, T.K.S. Mahapatra and Franz Schaefer

MARC

LEADER 00000caa a2200000 c 4500
001 1744215634
003 DE-627
005 20221123152814.0
007 cr uuu---uuuuu
008 210108s2020 xx |||||o 00| ||eng c
024 7 |a 10.1186/s12882-020-02153-5  |2 doi 
035 |a (DE-627)1744215634 
035 |a (DE-599)KXP1744215634 
035 |a (OCoLC)1341384914 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Basu, Biswanath  |e VerfasserIn  |0 (DE-588)1208788728  |0 (DE-627)169562470X  |4 aut 
245 1 0 |a Randomized clinical trial to compare efficacy and safety of repeated courses of rituximab to single-course rituximab followed by maintenance mycophenolate-mofetil in children with steroid dependent nephrotic syndrome  |c Biswanath Basu, Stella Preussler, Anja Sander, T.K.S. Mahapatra and Franz Schaefer 
264 1 |c 30 November 2020 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 08.01.2021 
520 |a Approximately 30% of children with idiopathic nephrotic syndrome develop a complicated course with frequent relapses or steroid dependency. Rituximab, a B cell depleting monoclonal antibody, is a safe and effective alternative to steroids or other immunosuppressants for achieving and maintaining remission in this population at short term. Despite the good initial response relapses inevitably occur after regeneration of B lymphocytes, necessitating either repeat courses of rituximab or addition of another steroid-sparing immunosuppressant. 
650 4 |a Childhood nephrotic syndrome 
650 4 |a Mycophenolate-Mofetil 
650 4 |a Rituximab 
650 4 |a Steroid dependent nephrotic syndrome 
700 1 |a Erdmann, Stella  |d 1991-  |e VerfasserIn  |0 (DE-588)1139143344  |0 (DE-627)897309510  |0 (DE-576)49295481X  |4 aut 
700 1 |a Sander, Anja  |d 1986-  |e VerfasserIn  |0 (DE-588)1071418173  |0 (DE-627)825832217  |0 (DE-576)433071567  |4 aut 
700 1 |a Mahapatra, T. K. S.  |e VerfasserIn  |4 aut 
700 1 |a Schaefer, Franz  |d 1961-  |e VerfasserIn  |0 (DE-588)1023365383  |0 (DE-627)718365577  |0 (DE-576)366705598  |4 aut 
773 0 8 |i Enthalten in  |t BMC nephrology  |d London : BioMed Central, 2000  |g 21(2020), Artikel-ID 520, Seite 1-11  |h Online-Ressource  |w (DE-627)326643672  |w (DE-600)2041348-8  |w (DE-576)107014629  |x 1471-2369  |7 nnas  |a Randomized clinical trial to compare efficacy and safety of repeated courses of rituximab to single-course rituximab followed by maintenance mycophenolate-mofetil in children with steroid dependent nephrotic syndrome 
773 1 8 |g volume:21  |g year:2020  |g elocationid:520  |g pages:1-11  |g extent:11  |a Randomized clinical trial to compare efficacy and safety of repeated courses of rituximab to single-course rituximab followed by maintenance mycophenolate-mofetil in children with steroid dependent nephrotic syndrome 
856 4 0 |u https://doi.org/10.1186/s12882-020-02153-5  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-020-02153-5  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20210108 
993 |a Article 
994 |a 2020 
998 |g 1023365383  |a Schaefer, Franz  |m 1023365383:Schaefer, Franz  |d 910000  |d 910500  |e 910000PS1023365383  |e 910500PS1023365383  |k 0/910000/  |k 1/910000/910500/  |p 5  |y j 
998 |g 1139143344  |a Erdmann, Stella  |m 1139143344:Erdmann, Stella  |d 910000  |d 999701  |e 910000PE1139143344  |e 999701PE1139143344  |k 0/910000/  |k 1/910000/999701/  |p 1  |x j 
998 |g 1071418173  |a Sander, Anja  |m 1071418173:Sander, Anja  |d 910000  |d 999701  |e 910000PS1071418173  |e 999701PS1071418173  |k 0/910000/  |k 1/910000/999701/  |p 2 
999 |a KXP-PPN1744215634  |e 3832559116 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title_sort":"Randomized clinical trial to compare efficacy and safety of repeated courses of rituximab to single-course rituximab followed by maintenance mycophenolate-mofetil in children with steroid dependent nephrotic syndrome","title":"Randomized clinical trial to compare efficacy and safety of repeated courses of rituximab to single-course rituximab followed by maintenance mycophenolate-mofetil in children with steroid dependent nephrotic syndrome"}],"person":[{"given":"Biswanath","display":"Basu, Biswanath","roleDisplay":"VerfasserIn","family":"Basu","role":"aut"},{"role":"aut","display":"Erdmann, Stella","given":"Stella","roleDisplay":"VerfasserIn","family":"Erdmann"},{"role":"aut","family":"Sander","roleDisplay":"VerfasserIn","given":"Anja","display":"Sander, Anja"},{"role":"aut","given":"T. K. S.","display":"Mahapatra, T. K. S.","family":"Mahapatra","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Schaefer, Franz","given":"Franz","family":"Schaefer","roleDisplay":"VerfasserIn"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"2020","dateIssuedDisp":"30 November 2020"}],"name":{"displayForm":["Biswanath Basu, Stella Preussler, Anja Sander, T.K.S. Mahapatra and Franz Schaefer"]},"language":["eng"],"id":{"doi":["10.1186/s12882-020-02153-5"],"eki":["1744215634"]},"note":["Gesehen am 08.01.2021"],"relHost":[{"id":{"zdb":["2041348-8"],"eki":["326643672"],"issn":["1471-2369"]},"language":["eng"],"pubHistory":["1.2000 -"],"disp":"Randomized clinical trial to compare efficacy and safety of repeated courses of rituximab to single-course rituximab followed by maintenance mycophenolate-mofetil in children with steroid dependent nephrotic syndromeBMC nephrology","type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"title_sort":"BMC nephrology","title":"BMC nephrology"}],"part":{"year":"2020","volume":"21","text":"21(2020), Artikel-ID 520, Seite 1-11","pages":"1-11","extent":"11"},"note":["Gesehen am 20. Januar 2016"],"origin":[{"publisher":"BioMed Central","dateIssuedDisp":"2000-","publisherPlace":"London","dateIssuedKey":"2000"}],"recId":"326643672","physDesc":[{"extent":"Online-Ressource"}]}],"recId":"1744215634","physDesc":[{"extent":"11 S."}]} 
SRT |a BASUBISWANRANDOMIZED3020